A resident who was vaccinated against the coronavirus on March 22 is being treated at a Melbourne hospital
Australian authorities are investigating a case of thrombosis in a resident who was vaccinated against coronavirus with AstraZeneca’s vaccine. The case is being investigated by Australia’s acting chief medical officer of health, Michael Kidd, ABC television reported Friday.
A 44-year-old patient who was vaccinated against the coronavirus on March 22 has been hospitalised with severe thrombosis and is being treated at a Melbourne hospital. “This case is currently being investigated by the Therapeutic Goods Administration (TGA) and there will be a meeting tomorrow morning to review the case and determine if it could be related to the AstraZeneca vaccine,” Kidd said.
“If you have been given the AstraZeneca vaccine and you experience persistent headaches or other worrying symptoms from day four to day 20 after vaccination, you should seek medical attention”, – the acting chief medical officer warned.
Australian authorities are already investigating whether there is a link between AstraZeneca vaccination and the occurrence of thrombosis, but stressed that the risk of contracting the coronavirus is much higher “than the likely threat of a rare blood clotting disorder after vaccination”.
On Thursday, the UK regulator reported 30 cases of thrombosis in people who received the AstraZeneca vaccine. A number of countries have suspended or restricted the use of the company’s vaccine as a precaution, but most have resumed use of the drug some time later.